Table 1.

Arm/Hand Swelling

		None	A little	Quite a bit	Very Much	p-value (little+)	p-value (quite a bit+)
POST OP	Overall ARM/HAND SWELLING (N=321)	250 (77.9%)	56 (17.4%)	11 (3.4%)	4 (1.2%)
	Vs Arm (N=321)					0.572	0.720
	CMF (Cyclophosphamide, Methotrexate and Fluorouracil) (N=67)	49 (73.1%)	15 (22.4%)	2 (3.0%)	1 (1.5%)
	AC (Doxorubicin and Cyclophosphamide) (N=99)	78 (78.8%)	15 (15.2%)	4 (4.0%)	2 (2.0%)
	Capecitabine (N=155)	123 (79.4%)	26 (16.8%)	5 (3.2%)	1 (0.6%)
	Vs Most Extensive Surgery (N=319)					0.621	0.359
	Breast Conserving Surgery (N=143)	113 (79.0%)	25 (17.5%)	4 (2.8%)	1 (0.7%)
	Full Mastectomy (N=176)	135 (76.7%)	31 (17.6%)	7 (4.0%)	3 (1.7%)
	Vs Axillary Dissection (N=321)					<0.001	0.046
	No (N=65)	62 (95.4%)	3 (4.6%)	0 (0%)	0 (0%)
	Yes (N=256)	188 (73.4%)	53 (20.7%)	11 (4.3%)	4 (1.6%)
	Vs RT (N=300)					0.570	0.789
	No (N=139)	110 (79.1%)	23 (16.6%)	4 (2.9%)	2 (1.4%)
	Yes (N=161)	123 (76.4%)	30 (18.6%)	6 (3.7%)	2 (1.2%)
	Vs Number of Nodes Examined (N=314)					<0.001	0.083
	0-3 (N=49)	45 (91.8%)	4 (8.2%)	0 (0%)	0 (0%)
	4-7 (N=53)	49 (92.5%)	3 (5.7%)	1 (1.9%)	0 (0%)
	8+ (N=212)	149 (70.3%)	49 (23.1%)	10 (4.7%)	4 (1.9%)
AT 12 MONTHS	Overall ARM/HAND SWELLING (N=259)	205 (79.2%)	38 (14.7%)	12 (4.6%)	4 (1.5%)
	Vs Arm (N=259)					0.957	0.226
	CMF (Cyclophosphamide, Methotrexate and Fluorouracil) (N=54)	43 (79.6%)	9 (16.7%)	2 (3.7%)	0 (0%)
	AC (Doxorubicin and Cyclophosphamide) (N=82)	64 (78.1%)	10 (12.2%)	6 (7.3%)	2 (2.4%)
	Capecitabine (N=123)	98 (79.7%)	19 (15.4%)	4 (3.3%)	2 (1.6%)
	Vs Most Extensive Surgery (N=257)					0.968	0.929
	Breast Conserving Surgery (N=117)	93 (79.5%)	17 (14.5%)	5 (4.3%)	2 (1.7%)
	Full Mastectomy (N=140)	111 (79.3%)	20 (14.3%)	7 (5.0%)	2 (1.4%)
	Vs Axillary Dissection (N=259)					0.320	0.628
	No (N=56)	47 (83.9%)	5 (8.9%)	3 (5.4%)	1 (1.8%)
	Yes (N=203)	158 (77.8%)	33 (16.3%)	9 (4.4%)	3 (1.5%)
	Vs RT (N=245)					0.368	0.415
	No (N=109)	90 (82.6%)	14 (12.8%)	5 (4.6%)	0 (0%)
	Yes (N=136)	106 (77.9%)	21 (15.4%)	6 (4.4%)	3 (2.2%)
	Vs Number of Nodes Examined (N=254)					0.479	0.582
	0-3 (N=44)	37 (84.1%)	4 (9.1%)	3 (6.8%)	0 (0%)
	4-7 (N=39)	32 (82.1%)	3 (7.7%)	1 (2.6%)	3 (7.7%)
	8+ (N=171)	131 (76.6%)	31 (18.1%)	8 (4.7%)	1 (0.6%)
AT 24 MONTHS	Overall ARM/HAND SWELLING (N=240)	193 (80.4%)	38 (15.8%)	8 (3.3%)	1 (0.4%)
	Vs Arm (N=240)					0.116	0.211
	CMF (Cyclophosphamide, Methotrexate and Fluorouracil) (N=49)	36 (73.5%)	9 (18.4%)	3 (6.1%)	1 (2.0%)
	AC (Doxorubicin and Cyclophosphamide) (N=83)	64 (77.1%)	17 (20.5%)	2 (2.4%)	0 (0%)
	Capecitabine (N=108)	93 (86.1%)	12 (11.1%)	3 (2.8%)	0 (0%)
	Vs Most Extensive Surgery (N=238)					0.202	0.039
	Breast Conserving Surgery (N=108)	91 (84.3%)	16 (14.8%)	1 (0.9%)	0 (0%)
	Full Mastectomy (N=130)	101 (77.7%)	21 (16.2%)	7 (5.3%)	1 (0.8%)
	Vs Axillary Dissection (N=240)					0.209	0.489
	No (N=52)	45 (86.5%)	6 (11.5%)	1 (1.9%)	0 (0%)
	Yes (N=188)	148 (77.7%)	32 (17.0%)	7 (3.7%)	1 (0.5%)
	Vs RT (N=226)					0.522	0.833
	No (N=100)	82 (82.0%)	14 (14.0%)	4 (4.0%)	0 (0%)
	Yes (N=126)	99 (78.6%)	23 (18.3%)	3 (2.4%)	1 (0.8%)
	Vs Number of Nodes Examined (N=236)					0.079	0.406
	0-3 (N=41)	38 (92.7%)	2 (4.9%)	1 (2.4%)	0 (0%)
	4-7 (N=39)	31 (79.5%)	5 (12.8%)	2 (5.1%)	1 (2.6%)
	8+ (N=156)	120 (76.9%)	31 (19.9%)	5 (3.2%)	0 (0%)